EvokAI Creative Labs

EvokAI Creative Labs FCF Yield

The Free Cash Flow Yield of EvokAI Creative Labs (OKAI.V) as of Oct 21, 2026 is -279.93 %. In the previous year, Free Cash Flow Yield was -36.21 % — a change of 673.07% (lower).

FCF Yield

-279.93 %

YoY

673.07%

Last updated:

Free Cash Flow Yield of EvokAI Creative Labs is 2023 -279.93 % . Free Cash Flow Yield of EvokAI Creative Labs was 2022 -36.21 % . It decreases by 673.07% lower compared to the previous year.

The EvokAI Creative Labs FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2020
-12.23 USD
Jan 1, 2021
-9.91 USD
Jan 1, 2022
-36.21 USD
Jan 1, 2023
-279.93 USD
The EvokAI Creative Labs FCF Yield history
YEARFCF YieldYoY
-279.93 %+673.07%
-36.21 %+265.51%
-9.91 %-18.97%
-12.23 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EvokAI Creative Labs Stock analysis

What does EvokAI Creative Labs do? EvokAI Creative Labs Inc develops AI algorithms for healthcare, deploying machine learning to search medical data and uncover insights for improved health outcomes. The company offers its AI solutions across the healthcare system, targeting hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations, medical professionals, patients, and healthy individuals. Its divisions include EvokAI Simulators, EvokAI Sensors, EvokAI Neurotrainer, and EvokAI Medical, with EvokAI Simulators combining cognitive neuroscience, virtual reality, and AI to assess cognitive performance and spatial perception. The company generates revenue by providing AI-driven insights and tools to healthcare stakeholders, including pharmaceutical companies and research institutions, for drug development, clinical decisions, and disease prevention. EvokAI Simulators specifically serves medical professionals and patients seeking cognitive assessments through virtual reality and AI integration. EvokAI Medical supports healthcare providers in delivering accurate diagnoses and improving patient experiences. EvokAI Sensors and EvokAI Neurotrainer cater to diverse healthcare segments, from early disease detection to enhancing cognitive training. The company's focus on preventing and early detecting diseases aligns with the needs of aging populations and health-conscious individuals, driving demand for its AI-powered solutions across the healthcare ecosystem. EvokAI Creative Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EvokAI Creative Labs stock

Free Cash Flow Yield of EvokAI Creative Labs is -279.93 % in 2023.

Free Cash Flow Yield of EvokAI Creative Labs changed from -36.21 % to -279.93 %, representing a 673.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield EvokAI Creative Labs since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's EvokAI Creative Labs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — EvokAI Creative Labs

All Key Metrics — EvokAI Creative Labs